An Amorphous And A Crystalline Form Of Genz 112638 Hemitartrate As Inhibitor Of Glucosylceramide Synthase

Patent No. EP2504332 (titled "An Amorphous And A Crystalline Form Of Genz 112638 Hemitartrate As Inhibitor Of Glucosylceramide Synthase") was filed by Genzyme on Nov 24, 2010. The application was issued on Mar 17, 2021.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZFeb 27, 2015ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2504332

GENZYME
Application Number
EP10785289A
Filing Date
Nov 24, 2010
Status
Patent Maintained As Amended
Feb 12, 2021
Publication Date
Mar 17, 2021